STRATA CRITICAL MEDICAL, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$2.65 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-04
- STRATA CRITICAL MEDICAL, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$487.00K, a 115.26% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$2.16M.
- STRATA CRITICAL MEDICAL, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$6.02M.
- STRATA CRITICAL MEDICAL, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $7.48M.
- STRATA CRITICAL MEDICAL, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $2.38M.
- STRATA CRITICAL MEDICAL, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was -$8.34M, a 192.14% decline from fiscal 2023.
- STRATA CRITICAL MEDICAL, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $9.05M, a 8.60% decline from fiscal 2022.
- STRATA CRITICAL MEDICAL, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $9.90M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 1 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 4 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 7 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$487.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$2.65M 10-Q · filed 2026-08-04 | -$8.66M derived: sum of 3 quarters · filed 2026-08-04 | -$1.18M derived: sum of 4 quarters · filed 2026-08-04 | |||||
| 2026-03-31 | -$2.16M 10-Q · filed 2026-05-06 | -$8.18M derived: sum of 2 quarters · filed 2026-05-06 | -$694.00K derived: sum of 3 quarters · filed 2026-05-06 | $2.50M derived: sum of 4 quarters · filed 2026-08-04 | |||||
| 2025-12-31 | -$6.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $1.46M derived: sum of 2 quarters · filed 2026-03-03 | $4.66M derived: sum of 3 quarters · filed 2026-08-04 | $2.38M 10-K · filed 2026-03-03 | |||||
| 2025-09-30 | $7.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $10.67M derived: sum of 2 quarters · filed 2026-08-04 | $8.39M 10-Q · filed 2025-11-10 | $8.39M derived: sum of 4 quarters · filed 2026-08-04 | |||||
| 2025-06-30 | $3.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $914.00K 10-Q · filed 2026-08-04 | $912.00K derived: sum of 3 quarters · filed 2026-08-04 | $101.00K derived: sum of 4 quarters · filed 2026-08-04 | |||||
| 2025-03-31 | -$2.28M 10-Q · filed 2026-05-06 | -$2.28M derived: sum of 2 quarters · filed 2026-05-06 | -$3.09M derived: sum of 3 quarters · filed 2026-05-06 | -$379.00K derived: sum of 4 quarters · filed 2026-05-06 | |||||
| 2024-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$813.00K derived: sum of 2 quarters · filed 2026-03-03 | $1.90M derived: sum of 3 quarters · filed 2026-03-03 | -$8.34M 10-K · filed 2026-03-03 | |||||
| 2024-09-30 | -$811.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.90M derived: sum of 2 quarters · filed 2025-11-10 | -$8.34M 10-Q · filed 2025-11-10 | -$3.37M derived: sum of 4 quarters · filed 2025-11-10 | |||||
| 2024-06-30 | $2.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$7.53M 10-Q · filed 2025-08-05 | -$2.56M derived: sum of 3 quarters · filed 2025-08-05 | $1.44M derived: sum of 4 quarters · filed 2025-08-05 | |||||
| 2024-03-31 | -$10.24M 10-Q · filed 2025-05-12 | -$5.27M derived: sum of 2 quarters · filed 2025-05-12 | -$1.27M derived: sum of 3 quarters · filed 2025-05-12 | $2.19M derived: sum of 4 quarters · filed 2025-05-12 | |||||
| 2023-12-31 | $4.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $8.96M derived: sum of 2 quarters · filed 2025-03-13 | $12.43M derived: sum of 3 quarters · filed 2025-03-13 | $9.05M 10-K · filed 2025-03-13 | |||||
| 2023-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $7.47M derived: sum of 2 quarters · filed 2024-11-12 | $4.09M 10-Q · filed 2024-11-12 | $9.73M derived: sum of 4 quarters · filed 2024-11-12 | |||||
| 2023-06-30 | $3.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $87.00K 10-Q · filed 2024-08-08 | $5.73M derived: sum of 3 quarters · filed 2024-08-08 | $8.71M derived: sum of 4 quarters · filed 2024-08-08 | |||||
| 2023-03-31 | -$3.38M 10-Q · filed 2024-05-07 | $2.26M derived: sum of 2 quarters · filed 2024-05-07 | $5.24M derived: sum of 3 quarters · filed 2024-05-07 | $3.88M derived: sum of 4 quarters · filed 2024-05-07 | |||||
| 2022-12-31 | $5.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $8.63M derived: sum of 2 quarters · filed 2024-03-12 | $7.26M derived: sum of 3 quarters · filed 2024-03-12 | $9.90M 10-K · filed 2024-03-12 | |||||
| 2022-09-30 | $2.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.62M derived: sum of 2 quarters · filed 2023-11-08 | $4.25M 10-Q · filed 2023-11-08 | $6.18M derived: sum of 4 quarters · filed 2023-11-08 | |||||
| 2022-06-30 | -$1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.27M 10-Q · filed 2023-08-09 | $3.20M derived: sum of 3 quarters · filed 2023-08-09 | $1.38M derived: sum of 4 quarters · filed 2023-08-09 | |||||
| 2022-03-31 | $2.64M 10-Q · filed 2023-05-11 | $4.56M derived: sum of 2 quarters · filed 2023-05-11 | $2.74M derived: sum of 3 quarters · filed 2023-05-11 | $3.29M derived: sum of 4 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | $1.92M 10-K · filed 2023-03-16 | $1.92M 10-QT · filed 2022-02-10 | $105.00K derived: sum of 2 quarters · filed 2023-03-16 | $652.00K derived: sum of 3 quarters · filed 2023-03-16 | $2.52M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-09-30 | -$1.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$1.27M derived: sum of 2 quarters · filed 2022-11-10 | $600.00K 10-Q · filed 2022-11-10 | $1.96M 10-K · filed 2023-03-16 | $1.96M 10-K · filed 2021-12-20 | ||||
| 2021-06-30 | $547.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $2.42M 10-Q · filed 2022-08-09 | $3.78M 10-Q · filed 2021-08-16 | $3.78M derived: sum of 4 quarters · filed 2023-01-10 | |||||
| 2021-03-31 | $1.87M 10-Q · filed 2022-05-10 | -$52.24K 10-Q · filed 2021-05-24 | $3.23M derived: sum of 2 quarters · filed 2023-01-10 | $3.23M derived: sum of 3 quarters · filed 2023-01-10 | $3.24M derived: sum of 4 quarters · filed 2023-01-10 | ||||
| 2020-12-31 | $1.36M 8-K · filed 2023-01-10 | $1.36M derived: sum of 2 quarters · filed 2023-01-10 | $1.37M derived: sum of 3 quarters · filed 2023-01-10 | $22.25K 10-K/A · filed 2021-05-07 | |||||
| 2020-09-30 | -$117.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $6.71K derived: sum of 2 quarters · filed 2020-11-10 | -$36.81K 10-Q · filed 2020-11-10 | -$1.41M 10-K · filed 2021-12-20 | |||||
| 2020-06-30 | $6.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$36.69K 10-Q · filed 2020-08-13 | -$1.59M 10-Q · filed 2021-08-16 | ||||||
| 2020-03-31 | -$43.52K 10-Q · filed 2021-05-24 | ||||||||
| 2019-12-31 | $136.69K 10-K/A · filed 2021-05-07 | ||||||||
| 2019-09-30 | $42.76K 10-Q · filed 2020-11-10 | -$402.00K 10-K · filed 2021-12-20 | |||||||
| 2019-06-30 | $1.00K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |